Martin P. Schrama is an expert Civil Trial Attorney as certified by the Supreme Court of New Jersey. He is also the Chair and Co-Founder of the Stark & Stark Mass Tort Litigation practice, as well as a member of the firm’s Commercial Litigation and Intellectual Property practices.
Mr. Schrama has extensive experience litigating on both the trial and appellate levels of the federal and state courts of New Jersey, Pennsylvania, and New York, as well as numerous other jurisdictions and arbitration fora throughout the nation, and is supervisory counsel for numerous Stark & Stark Litigation Teams.
Mr. Schrama primarily specializes in complex civil litigation matters, with a concentration in mass tort/class action prosecution and defense, and complex commercial litigation, involving environmental, pharmaceutical, commercial, employment, civil rights, investments/securities and consumer fraud claims.
Mr. Schrama has been appointed to leadership positions in national litigations. Some examples include:
- appointment as co-lead trial counsel in the state MCL and consolidated federal mass tort environmental contamination litigations, In re Bristol-Myers Squibb Environmental Contamination Litigation, No. 281 (N.J. Super. Ct. Law Div);
- appointment to the plaintiff’s steering committee for the state hernia mesh medical device MCL In Re: Proceed, No. 630 (N.J. Super. Ct. Law Div);
- appointment as a member of the bellwether committee for the federal anticoagulant medication MDL In re Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 02592 (E.D. La.);
- appointment as a member of numerous committees for the California HIV/AIDS medication JCCP Gilead Tenofovir Cases, JCCP No. 5043; and
- appointment as co-lead trial counsel in the federal employment class action Sheinberg, et al v. Sorensen, et al, Case No. 2:2000-cv-06041 (D.N.J.).
Mr. Schrama is also being considered for appointment to leadership positions in pending national litigations. Some examples include:
- appointment as co-lead trial counsel in the state civil rights class action Brown v. New Jersey Department of Corrections, HNT-L-76-19;
- appointment as co-lead trial counsel in the state derivative shareholder class action O’Connor, et al. v. Braun, et al., MER-C-68-19; and
- appointment as co-lead trial counsel in the federal life insurance class action Buck, et al v. American General Life Insurance Company, Case No.: 1:17-cv-13278 (D.N.J.)
Recently, Mr. Schrama was a member of the national trial team involved the first trial in the country of a TVT-Secur transvaginal mesh device case against Ethicon/Johnson and Johnson. The Plaintiff, a Stark & Stark client, was awarded a $20 million jury verdict.*
Mr. Schrama also recently served as counsel to a Fortune 500 financial corporation involved in a dispute over a detailed sale-leaseback transaction. The client was the subject of extensive claims, totaling in excess of $10 million. After several days of trial in federal court, Mr. Schrama was able to have all of the claims against his client dismissed in their entirety.*
Mr. Schrama also recently served as counsel to a multinational corporation involved in the sale and construction of emissions cleansing technology. The client was the subject of extensive claims, arising from the retrofitting of a major East Coast coal-burning powerplant. Mr. Schrama successfully defended the combined claims emanating from multiple arbitration proceedings, which exceeded $50 million.*
Mr. Schrama also recently represented a large industrial party to a solar power project. At the time, the project constituted the largest solar power installation of its kind in the United States and the twelfth largest in the world. Mr. Schrama successfully defended combined potential claims in excess of $18.5 million in state court.*
Mr. Schrama is a frequent contributor to the Mass Tort Law Blog.
Certified by the Supreme Court of New Jersey as a Civil Trial Attorney
NOTE: Any information about verdicts or settlements obtained are based on the unique facts of each case. Although these results were obtained by our firm, they may not indicate the probability of success or implied value of any other case. This amount reflects the gross recovery in the case (before attorneys’ fees and expenses).